Iontocaine
Company: Iomed
Approval Status: Approved May 1996
Treatment for: dermal surgery
Areas: Dermatology/Plastic Surgery; Neurology; Pharmacology/Toxicology
| General Information | Clinical Results |
General Information
Iontocaine has been approved as a needle-free anesthetic for use while performing painless dermal surgery. Iontocaine works by causing a loss of feeling or pain sensation in the skin. Iontocaine is transferred through the skin using iontophoresis, a virtually painless procedure that does not require a needle injection. Iontophoresis entails using adhesive pads that are filled with Iontocaine and placed on the skin similar to a bandage. The medication is then transferred using slight, barely noticeable electrical currents through Iomed's drug delivery system. The needle-free application distributes the Iontocaine evenly to the treatment area permitting pain-free procedures.
Iontocaine is approved for both pediatric and dermatology procedures that require anesthesia and will be introduced in certain United States market segments this year. Iontacaine is a solution of 2% lidocaine hydrochloride and epinephrine 1:100,000 produced for Iomed by Abbott Laboratories.
Clinical Results
This approval follows extensive clinical trials conducted on nearly 400 adult and pediatric subjects prior to a variety of procedures including dermal biopsies, dermal laser surgery, and veripuncture.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
